top of page
CA.jpg

IN THE STATES

CALIFORNIA

The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in California in 2022.

CA.png

Economic
Output

$276.9B

Direct Jobs Supported by the Industry

174,153

Total Jobs Supported

778,351

State Total Vendor Relationships

7,672

State Total Vendor Spending

$7,179,757,191

Clinical
Trials

2,152

Investments at Clinical Trial Sites

$1.84B

Clinical Trial Participants

102,669

Total Economic Impact of Clinical Trial Sites

$5.38B

bottom of page